Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapy

British Journal of Dermatology

Volumn 140, Issue 3, 1999, Pages 514-517

  Stables, G I ^a   Stringer, M R ^b   Robinson, D J ^b   Ash, D V ^b  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Aminolaevulinic acid; Erythroplasia of Queyrat; Photodynamic therapy; Topical

Indexed keywords

AMINOLEVULINIC ACID; MERCK OINTMENT; POLYURETHAN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; DRUG DOSAGE FORM; DRUG EFFECT; DRUG EFFICACY; DRUG SELECTIVITY; ERYTHROPLASIA; HUMAN; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RECURRENCE RISK; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; AGED; AMINOLEVULINIC ACID; CARCINOMA IN SITU; ERYTHROPLASIA; HUMANS; MALE; MIDDLE AGED; PENILE NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; TREATMENT OUTCOME;

EID: 0032939392     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.02720.x     Document Type: Article

References (20)

1. 1 Queyrat L. Erythroplasie du gland. Bull Soc Fr Dermatol Syphiligr 1911; 22: 378-82.
2. 2 Schellhammer PF, Jordan GH, Robey EL, Spaulding JT. Premalignant lesions and nonsquamous malignancy of the penis and carcinoma of the scrotum. Urol Clin N Am 1992; 19: 131-42.
3. 3 Graham JH, Helwig EB. Erythroplasia of Queyrat. A clinicopathologic and histochemical study. Cancer 1973; 32: 1396-414.
4. 4 Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B Biol 1990; 6: 143-8.
5. 5 Cairnduff F, Stringer MR, Hudson EJ et al. Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. Br J Cancer 1994; 69: 605-8.
6. 6 Mikhail GR. Cancers, precancers and pseudocancers on the male genitalia: a review of clinical appearances, histopathology and management. J Dermatol Surg Oncol 1980; 6: 1027-35.
7. 7 Kaye V, Zhang G, Dehner LP, Fraley EE. Carcinoma in situ of penis. Is distinction between erythroplasia of Queyrat and Bowen's disease relevant? Urology 1990; 36: 479-82.
8. 8 Goette DK, Elgart M, de Villez R. Erythroplasia of Queyrat: treatment with topically applied fluorouracil. JAMA 1975; 232: 934-7.
9. 9 Dawber R, Colver G, Jackson A. Premalignant lesions. In: Cutaneous Cryosurgery (Dawber R, Colver G, Jackson A, eds). London: Martin Dunitz, 1992; 77-93.
10. 10 Hanash KA, Furlow NL, Utz DC et al. Carcinoma of the penis: a clinicopathologic study. J Urol 1970; 104: 291-7.
11. 11 Mohs PE, Snow SN, Larson PO. Mohs micrographic surgery for penile tumours. Urol Clin N Am 1992; 19: 291-304.
12. 12 Grabstald H, Kelley CD. Radiation therapy of penile cancer. Urology 1980; 15: 575-6.
13. 13 Rosemberg SK, Fuller TA. Carbon dioxide rapid superpulsed laser treatment of erythroplasia of Queyrat. Urology 1980; 16: 181-2.
14. 14 Greenbaum SS, Glogau R, Stegman SJ, Tromovitch TA. Carbon dioxide laser treatment of erythroplasia of Queyrat. J Dermatol Surg Oncol 1989; 15: 747-50.
15. 15 Roberts DJH. Stables GI, Ash DV, Brown SB, Distribution of protoporphyrin IX in Bowen's disease and basal cell carcinomas treated with topical 5-aminolaevulinic acid. SPIE Proc 1995; 2371: 490-4.
16. 16 Svanberg K, Andersson T, Killander D et al. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-amino laevulinic acid sensitization and laser irradiation. Br J Dermatol 1994; 130: 743-51.
17. 17 Collins P, Robinson DJ, Stringer MR et al. The variable response of plaque psoriasis after a single treatment with topical 5-aminolaevulinic acid photodynamic therapy. Br J Dermatol 1997; 137: 743-9.
18. 18 Robinson DJ. In vivo analysis of the fluorescence dynamics of photosensitisers used in photodynamic therapy. PhD Thesis, Research School of Medicine, University of Leeds, 1998.
19. 19 Hudson EJ, Stringer MR, Cairnduff F et al. The optical properties of skin tumours measured during superficial photodynamic therapy. Lasers Med Sci 1994; 9: 99-103.
20. 20 Robinson DJ, de Bruijn RS, van der Veen N et al. Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and fluence rate and the resulting biological effect. Photochem Photobiol 1998; 67: 140-9.